Pharma Companies, Production and Synthetic Chemistry

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Pharma Companies

Production

Synthetic Chemistry

Re-Imagining Med Chem Strategies: the Tyranny of the n+1 Compound

DrugBaron

FEBRUARY 7, 2022

That’s the part of the process that’s analgous to the library evolution phase of Galaxy The classical approach beloved of large pharma companies is really a brute-force method: make as many molecules as you can to assemble the SAR. Not just more data per week. Definitely not just more compounds per week. More answers.

Small Molecule

Small Molecule Synthetic Chemistry Pharma Companies Pharmacokinetics

Women in Stem with Dr Mrunal Jaywant

Drug Target Review

JANUARY 19, 2024

As a head of analytical R&D, I worked until late at night to help my production team make correct decisions and fulfil all timeline commitments. The project has helped the United States Pharmacopeia (USP) deal with the challenges caused by drug product recalls due to unsafe levels of nitrosamine impurities.

Synthetic Chemistry

Synthetic Chemistry Analytical Chemistry Pharmaceuticals Pharma Companies

Drug Discovery Digest

Re-Imagining Med Chem Strategies: the Tyranny of the n+1 Compound

Women in Stem with Dr Mrunal Jaywant

Stay Connected